- Home
- OIS vs TVRD Comparison
OIS vs TVRD Comparison
Compare OIS & TVRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OIS
- TVRD
- Stock Information
- Founded
- OIS 1995
- TVRD 2017
- Country
- OIS United States
- TVRD United States
- Employees
- OIS N/A
- TVRD N/A
- Industry
- OIS Metal Fabrications
- TVRD Biotechnology: Pharmaceutical Preparations
- Sector
- OIS Industrials
- TVRD Health Care
- Exchange
- OIS Nasdaq
- TVRD Nasdaq
- Market Cap
- OIS 285.8M
- TVRD 246.5M
- IPO Year
- OIS 2001
- TVRD N/A
- Fundamental
- Price
- OIS $5.59
- TVRD $29.92
- Analyst Decision
- OIS Buy
- TVRD Strong Buy
- Analyst Count
- OIS 2
- TVRD 5
- Target Price
- OIS $7.25
- TVRD $59.20
- AVG Volume (30 Days)
- OIS 599.0K
- TVRD 23.2K
- Earning Date
- OIS 10-29-2025
- TVRD 08-14-2025
- Dividend Yield
- OIS N/A
- TVRD N/A
- EPS Growth
- OIS N/A
- TVRD N/A
- EPS
- OIS 0.11
- TVRD N/A
- Revenue
- OIS $664,287,000.00
- TVRD N/A
- Revenue This Year
- OIS N/A
- TVRD N/A
- Revenue Next Year
- OIS $5.23
- TVRD N/A
- P/E Ratio
- OIS $51.58
- TVRD N/A
- Revenue Growth
- OIS N/A
- TVRD N/A
- 52 Week Low
- OIS $3.08
- TVRD $8.13
- 52 Week High
- OIS $5.99
- TVRD $34.31
- Technical
- Relative Strength Index (RSI)
- OIS 62.23
- TVRD 65.43
- Support Level
- OIS $5.38
- TVRD $22.91
- Resistance Level
- OIS $5.14
- TVRD $31.54
- Average True Range (ATR)
- OIS 0.17
- TVRD 1.65
- MACD
- OIS 0.06
- TVRD 0.61
- Stochastic Oscillator
- OIS 92.72
- TVRD 81.28
About OIS Oil States International Inc.
Oil States International Inc is a provider of manufactured products and services to the energy, industrial and military sectors. Manufactured products include engineered capital equipment as well as products consumed in the drilling, well construction and production of oil and natural gas. The company sells its products and services to national oil and natural gas companies, oil and natural gas companies, onshore and offshore drilling companies and other oilfield services, defense and industrial companies. The company operates through three business segments, Offshore Manufactured Products, Completion and Production Services and Downhole Technologies. It gains maximum revenue from Offshore Manufactured Products.
About TVRD Tvardi Therapeutics Inc. Common Stock
Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.